Researchers from Peking University have conducted a comprehensive systematic review on the integration of machine learning into statistical methods for disease risk prediction models, shedding light on the potential of such integrated models in clinical diagnosis and screening practices.
Daiichi Sankyo and MSD expand collaboration for ADCs
MK-6070 was acquired by MSD through its purchase of Harpoon Therapeutics. Credit: Merck & Co., Inc., Rahway, NJ USA, and its affiliates. Daiichi Sankyo and